Evidence mapPaperPMID 36547925Full record

ArticleMarine drugs2022

New Dibenzo-

Jinxin Zhang, Baodan Zhang, Lei Cai, Ling Liu

Abstract read
In one paragraph

Article in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Bioactive α-Pyrone Analogs from the Endophytic FungusMolecules (Basel, Switzerland) · 2024
    Article
  7. Natural resorcylic lactones derived from alternariol.Beilstein journal of organic chemistry · 2024
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jinxin ZhangState Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.ORCID 0000-0002-6311-4174
Baodan ZhangState Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
Lei CaiState Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
Ling LiuState Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.ORCID 0000-0002-4882-0396

Funding

National Key Research and Development Program of China 2022YFC2303100the National Natural Science Foundation of China 32022002 and 21977113
6 · The paper itself

Abstract

Three new dibenzo-

Indexed as

alpha-GlucosidasesPyronesAlternariaAntioxidantsGlycoside Hydrolase InhibitorsMolecular Docking SimulationMolecular Structurealpha-GlucosidasesAntioxidantsGlycoside Hydrolase InhibitorsPyronesAlternaria alternataantioxidantbiological activitiesdibenzo-α-pyronemarine-derived fungusmolecular dockingOSMACα-glucosidase inhibition

Identifiers

PMID36547925
PMCPMC9785194

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.